Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / S&P BIOTECH
-
Number of holders
-
189
-
Total 13F shares, excl. options
-
44,401,036
-
Shares change
-
+1,061,017
-
Total reported value, excl. options
-
$2,294,153,280
-
Value change
-
+$45,889,608
-
Put/Call ratio
-
142%
-
Number of buys
-
97
-
Number of sells
-
96
-
Price
-
$51.66
Institutional Holders of SPDR SERIES TRUST - S&P BIOTECH (XBI) as of Q1 2016
As of 31 Mar 2016 SPDR SERIES TRUST - S&P BIOTECH (XBI) had 295 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 44,401,036 shares of stock of the company.
Largest 10 holders included GOLDMAN SACHS GROUP INC, MORGAN STANLEY, BANK OF AMERICA CORP /DE/, JPMORGAN CHASE & CO, CITIGROUP INC, BNP PARIBAS ARBITRAGE, SA, UBS Group AG, CREDIT SUISSE AG/, ORBIMED ADVISORS LLC, and WELLS FARGO & COMPANY/MN.
This table shows 295 institutional shareholders of the security as of 31 Mar 2016.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.